HomeProductsBuilding BlocksHeterocyclic ScaffoldsBenzoxazolesBifeprunox
Chemical structure of CAS 350992-10-8

Bifeprunox

CAS No.350992-10-8
MDL No.N/A
MFC24H23N3O2
MW385.50
InChI KeyCYGODHVAJQTCBG-UHFFFAOYSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

Bifeprunox is a biphenyl compound.

CAS No.350992-10-8
Product NameBifeprunox

Biological Targets

DRD2·HTR1A

Associated Conditions

bipolar disorder·schizophrenia·bipolar I disorder·Alzheimer disease·schizoaffective disorder·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

In vivo occupancy of dopamine D2 receptors by antipsychotic drugs and novel compounds in the mouse striatum and olfactory tubercles.

Naunyn-Schmiedeberg's archives of pharmacology • Vol. 373, Issue 6 • 2006
PMID: 16947046DOI: 10.1007/s00210-006-0092-z

Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.

European journal of pharmacology • Vol. 535, Issue 1-3 • 2006
PMID: 16554049DOI: 10.1016/j.ejphar.2006.01.051

Differential profile of antipsychotics at serotonin 5-HT1A and dopamine D2S receptors coupled to extracellular signal-regulated kinase.

European journal of pharmacology • Vol. 534, Issue 1-3 • 2006
PMID: 16497294DOI: 10.1016/j.ejphar.2006.01.027

Antipsychotic-like vs cataleptogenic actions in mice of novel antipsychotics having D2 antagonist and 5-HT1A agonist properties.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology • Vol. 31, Issue 9 • 2006
PMID: 16237379DOI: 10.1038/sj.npp.1300940

Documentation

Similar Products